Previous close | 74.26 |
Open | 74.50 |
Bid | 74.84 x 900 |
Ask | 75.48 x 1200 |
Day's range | 74.42 - 75.67 |
52-week range | 48.35 - 79.43 |
Volume | |
Avg. volume | 5,918,322 |
Market cap | 110.146B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 60.91 |
EPS (TTM) | 1.23 |
Earnings date | 24 Oct 2024 - 28 Oct 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 87.44 |
Integer Holdings' (ITGR) second-quarter results reflect robust Medical Sales, along with strength in all the product lines.
HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
Avanos' (AVNS) strong product line and focus on R&D raise optimism about the stock.